Skip to main content
Premium Trial:

Request an Annual Quote

Todos Medical: Priyanka Misra, Elise Brownell

Todos Medical has appointed Priyanka Misra VP of corporate development and Elise Brownell VP of R&D. Misra previously was a senior investment analyst at Feller Advisors. Prior to that, she was at Goldman Sachs Asset Management in the Alternative Investments and Manager Selection group. Brownell started her career at the State University of New York, Stony Brook before moving to Frederick Cancer Research Facility and Bayer Healthcare.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.